PROTECT TAVI - Prospective Randomized Outcome Study in TAVI Patients Undergoing Periprocedural Embolic Cerebral Protection With the Sentinel™ Device

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 328 participants.

Also called NCT02895737

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose supportive care
Phase
Not applicable
Enrolled
  • 328 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02895737
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Germany (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02895737. Randomized; single masking; primary purpose supportive care. Start 2016-12-28 (actual); primary completion 2021-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
PROTECT TAVI - Prospective Randomized Outcome Study in TAVI Patients Undergoing Periprocedural Embolic Cerebral Protection With the Sentinel™ Device
Acronym
PROTECT
Condition
Cerebral Embolization During TAVI Using Balloon-expandable vs. Self-expandable Valves
Intervention (Device)
TAVI: Edwards SAPIEN 3, Edwards Lifesciences, Edwards Sapien Ultra
Intervention (Device)
TAVI: Edwards SAPIEN 3, Edwards Lifesciences, Edwards Sapien Ultra; Sentinel™ Cerebral Protection Systems
Intervention (Device)
TAVI: CoreValve® Evolut R™, CoreValve Medtronic
Intervention (Device)
TAVI: CoreValve® Evolut R™, CoreValve Medtronic; Sentinel™ Cerebral Protection Systems
Lead sponsor
Deutsches Herzzentrum Muenchen (class: other)

Record details

Record id
cardio:ct-nct02895737
Content hash
b7efc2061bb19ce40c5f4fb61426da17c9858f2cb4c98d040116a5de2938321e